Clinical trial
Special Drug Use Investigation of Nexavar (Unresectable Hepatocellular Carcinoma)
NCT01411436 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Special Drug Use Investigation of Nexavar (Unresectable Hepatocellular Carcinoma)
- Lead sponsor
- Bayer
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2009
- Completion date
- February 28, 2015
- Enrollment
- 1,637 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.